Wednesday, July 12, 2017, at 7:00PM CEST - Recording Available
This one-hour webinar will address PD-L1 assessment as a biomarker for immunotherapy.
Wednesday, July 12, 2017, at 9:00 PM EDT - Recording Available
This live session of IASLC Lung Cancer Grand Rounds features Dr. Karen Kelly.
Wednesday, June 21, 2017 at 9:00PM EDT - Recording Available
This live session of IASLC Lung Cancer Grand Rounds features Dr. Gregory Riely. In this program Dr. Riely will review recent advances in our understanding of the biology and treatment of thoracic neuroendocrine tumors.
Tuesday, June 20, 2017 at 7:00PM CEST (Central European Summer Time) - Recording Available
Dr. Scagliotti and Dr. Van Houtte explore adjuvant therapy of lung cancer in this one-hour webinar.
Monday, May 15, 2017 - 6:00PM CEST (Central European Summer Time) - Recording Available
Cancer immunotherapy is emerging as one of the most promising areas of cancer research and treatment.Overall, the goal of cancer immunotherapy is to stimulate a patient's immune system to recognize cancer cells as foreign and attack them.
Tuesday, May 9, 2017 at 9:00PM EDT - Recording Available
This webinar will provide an updated overview of current standard therapies for stage III NSCLC. It will also review the most recent data and current trials likely to impact standards of care.
Wednesday, May 3, 2017,11:00AM EDT / 9:00AM MDT - Recording Available
This webinar will feature two presentations and will be followed by a question and answer session.
Wednesday, April 19, 2017 at 9:00PM EDT - Recording Available
In this program, we will cover: the incidence and epidemiology of brain metastases in NSCLC; its prognostic implications; current management, including surgical, radiation and systemic options.
Tuesday, March 21, 2017 at 9:00PM EST - Recording Available
With the integration of immunotherapy in the treatment of non-small cell lung cancer, recognition of potential side effects associated with immunotherapy and management of symptoms are essential components of overall care.
Thursday March 16, 2017 at 9:00PM EST - Recording Available
In this program we will examine the evolving therapeutic landscape for the treatment of squamous cell non-small cell lung cancer. The introduction of immune checkpoint inhibitors into treatment algorithms is the primary catalyst of new therapeutic options.